These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1681184)

  • 21. [Barrett esophagus: epidemiologic data and risk of becoming malignant].
    García Marcilla JA; Parrilla Paricio P; Ortiz Escandell MA; Martínez de Haro LF; Aguado Albasini JL; Molina Martínez J; Rodríguez Bermejo M
    Rev Esp Enferm Apar Dig; 1989 Nov; 76(5):419-23. PubMed ID: 2694239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smoking found to increase the rate of progression of Barrett esophagus to adenocarcinoma.
    Barton MK
    CA Cancer J Clin; 2012; 62(4):215-6. PubMed ID: 22614544
    [No Abstract]   [Full Text] [Related]  

  • 23. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
    Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
    Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adiposity and columnar-lined esophagus.
    Lenglinger J; Eisler M; Riegler FM
    Am J Gastroenterol; 2008 May; 103(5):1316-7. PubMed ID: 18477363
    [No Abstract]   [Full Text] [Related]  

  • 25. Barrett's esophagus and cytokine polymorphisms-confusion about the content in the abstract/results section compared to the table given in a recent manuscript.
    Leodolter A
    Am J Gastroenterol; 2005 Dec; 100(12):2814. PubMed ID: 16393242
    [No Abstract]   [Full Text] [Related]  

  • 26. Management strategies for Barrett's esophagus.
    Hillman L
    J Gastroenterol Hepatol; 2007 Jun; 22(6):771-2. PubMed ID: 17565627
    [No Abstract]   [Full Text] [Related]  

  • 27. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis.
    Yousef F; Cardwell C; Cantwell MM; Galway K; Johnston BT; Murray L
    Am J Epidemiol; 2008 Aug; 168(3):237-49. PubMed ID: 18550563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Esophagoscopic monitoring of Barrett's esophagus--additional life years of good quality or wasting of limited resources?].
    Voutilainen M
    Duodecim; 2010; 126(5):507-14. PubMed ID: 20597303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The incidence of esophageal adenocarcinoma in Barrett's esophagus has been overestimated.
    Desai TK; Singh J; Samala N; Subbiah P
    Am J Gastroenterol; 2011 Jul; 106(7):1364-5; author reply 1365-6. PubMed ID: 21731021
    [No Abstract]   [Full Text] [Related]  

  • 30. The incidence of esophageal adenocarcinoma among patients with nondysplastic Barrett's esophagus has been overestimated.
    Desai TK; Samala N
    Clin Gastroenterol Hepatol; 2011 Apr; 9(4):363-4; author reply 364-5. PubMed ID: 21115135
    [No Abstract]   [Full Text] [Related]  

  • 31. The epidemiology of esophageal carcinoma. The changing face of a disease.
    Kirby TJ; Rice TW
    Chest Surg Clin N Am; 1994 May; 4(2):217-25. PubMed ID: 8049992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathogenesis and epidemiology of Barrett esophagus].
    Spechler SJ
    Chirurg; 1994 Feb; 65(2):84-7. PubMed ID: 8162820
    [No Abstract]   [Full Text] [Related]  

  • 33. Barrett's esophagus and cancer risk: a more realistic estimate.
    Rajendra S; Sharma P
    Semin Thorac Cardiovasc Surg; 2011; 23(4):261-2. PubMed ID: 22443641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barrett's Registries in Europe: report of an International Workshop.
    Caygill CP; Zaninotto G; Rugge M;
    Eur J Cancer Prev; 2008 Oct; 17(5):426-9. PubMed ID: 18714184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology?
    Prach AT; MacDonald TA; Hopwood DA; Johnston DA
    Lancet; 1997 Sep; 350(9082):933. PubMed ID: 9314878
    [No Abstract]   [Full Text] [Related]  

  • 36. Re: Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.
    Rugge M; Fassan M; Cavallin F; Zaninotto G
    J Natl Cancer Inst; 2012 Nov; 104(22):1771-2. PubMed ID: 23042934
    [No Abstract]   [Full Text] [Related]  

  • 37. The incidence of adenocarcinoma and squamous cell carcinoma of the esophagus: Barrett's esophagus makes a difference.
    van Blankenstein M; Looman CW; Hop WC; Bytzer P
    Am J Gastroenterol; 2005 Apr; 100(4):766-74. PubMed ID: 15784017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteration of Esophageal Microbiome by Antibiotic Treatment Does Not Affect Incidence of Rat Esophageal Adenocarcinoma.
    Sawada A; Fujiwara Y; Nagami Y; Tanaka F; Yamagami H; Tanigawa T; Shiba M; Tominaga K; Watanabe T; Gi M; Wanibuchi H; Arakawa T
    Dig Dis Sci; 2016 Nov; 61(11):3161-3168. PubMed ID: 27461059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study.
    Anderson LA; Watson RG; Murphy SJ; Johnston BT; Comber H; Mc Guigan J; Reynolds JV; Murray LJ
    World J Gastroenterol; 2007 Mar; 13(10):1585-94. PubMed ID: 17461453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus.
    Holmberg D; Ness-Jensen E; Mattsson F; El-Serag HB; Lagergren J
    Eur J Cancer; 2017 Apr; 75():41-46. PubMed ID: 28214656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.